טוען...
Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia
Hyperuricemia has been identified as an independent risk factor for chronic kidney disease (CKD) and is associated with the progression of kidney diseases. It remains unknown whether enhancer of zeste homolog 2 (EZH2), a histone H3 lysine 27 methyltransferase, can regulate metabolism of serum uric a...
שמור ב:
| הוצא לאור ב: | Am J Physiol Renal Physiol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Physiological Society
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6734054/ https://ncbi.nlm.nih.gov/pubmed/30566000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00234.2018 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|